Balchem Corporation
CompanyUnited StatesFounded 1967
Balchem Corporation develops one asset, in phase 1 (Choline in Alzheimer's disease). Mostly supplement; based in the United States, founded in 1967.
- 1
- Asset
- Furthest stage
- Phase 1
- 0
- Trials
- 4
- Signals
Pipeline
1Supplies choline for phospholipid synthesis, with potential effects on lipid metabolism in APOE4 carriers.
Phase 1, Supplement, Alzheimer's disease
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals20
- Similar companies6
Papers
Effect of choline supplementation in presymptomatic APOE ε4 carriers: a pilot study
Alzheimer's & dementia (New York, N. Y.), Sep 16, 2026
Perspective: Estrogen and the Risk of Cognitive Decline: A Missing Choline(rgic) Link?
Advances in nutrition (Bethesda, Md.), Dec 2, 2021